New original metabolitotropic endothelioprotector "Angiolin": quantum-chemical parameters and peculiarities of pharmacological action

TitleNew original metabolitotropic endothelioprotector "Angiolin": quantum-chemical parameters and peculiarities of pharmacological action
Publication TypeJournal Article
Year of Publication2017
AuthorsChekman, IS, Kazakova, OA, Mazur, IA, Nagornaya, EA, Belenichev, IF, Gorchakova, NA, Buhtiyarova, NV, Syrova, AO, Dovhan, RS, Zahorodnyi, MI
Abbreviated Key TitleDopov. Nac. akad. nauk Ukr.
Date Published8/2017

By means of the density functional theory with the use of the solvation model IEF PCM, the electronic and energetic properties of "Angiolin" are researched. It is established that the equilibrium structure with the lowest level of Gibbs free energy is stabilized by intramolecular oxygen bonds, and the main reaction centers are ionic groups, the groups participating in H- bonds and the heterocycle of thiotriazoline.

Keywordscardiop rotec tive activity, endothelioprotective activity, functional groups, neuroprotective activity, quantum-chemical parameters, “Angiolin”
  1. Belenichev, I. F, Cherniy, V. I., Nagornaya, E. A., Bukhtiyarova, N. V. & Kucherenko, V. I. (2015). Neuro protection and neuroplasticity. Kiev: Logos (in Russian).
  2. Kohn, W. & Sham, L. J. (1965). Self-consistent equations including exchange and correlation effects. Phys. Rev., 140, No. 4, pp. 1133-1145.
  3. Becke, A. D. (1993). Density-functional thermochemistry. III. The role of exact exchange. J. Chem. Phys., 98, No. 18, pp. 5648-5661.
  4. Tomasi, J., Mennucci, B. & Cammi, R. (2005). Quantum Mechanical Continuum Solvation Models. Chem Rev., 105, No. 8, pp. 2999-3093.
  5. Schmidt, M. W., Baldridge, K. K., Boatz, J. A., Elbert, S. T., Gordon, M. S., Jensen, J. J., Koseki, S., Matsunaga, N., Nguyen, K. A., Su, S., Windus, T. L., Dupuis, M. & Montgomery, J. A. (1993). General atomic and molecular electronic structure systems. J. Comput. Chem., 14, No. 11, pp. 1347-1355.
  6. Granovsky, A. A. Firefly version 8. Retrievered from
  7. Cheeseright, T., Mackey, M., Rose, S. & Vinter, A. (2006). Molecular field extrema as descriptors of bio logical activity: definition and validation. J. Chem. Inf. Model., 46, No. 2, pp. 665-676.
  8. Kazakova, O. A. (2011). Interaction of bioactive molecules with highly dispersed silica surface in aqueous medium: quantum chemical investigation. Poverhnost, Iss. 3, pp.13-21 (in Russian).
  9. Belenichev, I. F., Mazur, I. A. & Bukhtiayrova, N. V. (2013). The endothelium — protective effect of 3-methyl-1,2,4-triazolyl-5-thioacrtate(S)-2,6-diaminohoexanic acid (lysinium): effects on the expression of vas cular endothelial growth factor (VEGF) and the characteristics of the endotheliocytes of the cerebral vessels of animals with cerebral ischemia. Neurochem. J., 7, No.4, pp. 296-303.
  10. Belenichev, I. F., Kucherenko, L. I., Nagornaya, E. A., Mazur, I. A. & Bukhtiyarova, N. V. (2015). Functional nitric oxide conjugate systems state/restored heart thiols of rats in modeling isadrine-pituitrin's myocardial infarction using metabolitetropic cardioprotector “Angiolin”. Int. J. Basic Clin. Pharmacol., 4, No. 1, pp. 1-5.
  11. Kolesnik, Yu. M., Chekman, I. S., Mazur, I. A., Belenichev, I. F., Gorchakova, N. A. & Nagornaia, E. A. (2014). Mechanisms of development of endothelial dysfunction and search for endothelioprotectors. Zh. NAMN Ukrayiny, 20, No. 3, pp.289-299 (in Ukrainian).
  12. Belenichev, I. F., Mazur, I. A.,Kucherenko, L. I. & Nagornaya, E. A. (2016). The molecular and ultrastructural aspects of the formation of mitochondrial dysfunction in the modeling of chronic cerebral ischemia: the mitoprotective effects of angiolin. Neurochem. J., 10, No. 2, pp. 131-136.